Bristol-Myers Squibb Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (55)

Latest Posts

About This Stock More About This Stock
Week In Review: Cathay Fortune Pays $186 Million For German Diagnostic Company
Article By: ChinaBio® Today
Saturday, April 29, 2017 1:45 PM EDT
Cathay Fortune International, a Shanghai healthcare private equity firm, will acquire Berlin's Epigenomics AG for $186 million in cash. Cathay will acquire Epigenomics through a subsidiary, Blitz F16-83.
In this article: BMY, LLY, MRK, PFE, EPGNF, AMRI, PRTK
Read
Bristol-Myers Squibb: Strong Earnings Could Warrant Higher Dividend Growth Ahead
Article By: SureDividend
Friday, April 28, 2017 10:01 AM EDT
Bristol-Myers has a low payout ratio, a high level of profitability, and a strong balance sheet. These are the ingredients that should allow the company to raise its future dividend increases, possibly in the mid-single digit range.
In this article: BMY
Read
A Deluge And An Eclipse
Article By: Marvin R Clark
Thursday, April 27, 2017 11:33 PM EDT
Today brought a deluge of earnings.Google parent Alphabet posted a 29 percent rise in quarterly profit, driven by a surge in advertising on mobiles and its popular YouTube video service.
In this article: BMY, DPZ, F, KKR, LNKD, LUV, UPS, AMZN, GOOG, INTC, MSFT, SBUX, AAL, ABBV, GOOGL, CCV
Read
Bristol-Myers Squibb Co. Ups Forecast As Q1 Earnings Beat The Street
Article By: Lorimer Wilson
Thursday, April 27, 2017 11:27 AM EDT
Bristol-Myers Squibb Co. early Thursday posted much better than expected first quarter earnings results and lifted its full-year outlook, as sales of several of its new drugs begin to skyrocket.
In this article: BMY
Read
Biotechs Running Again: Life Science Stocks
Article By: Rod Raynovich
Tuesday, April 25, 2017 11:59 PM EDT
Biotechs are running again taking the cue from Nasdaq which is up 3.44% in April after a brief mid-month sell-off. Biotech stocks rallied from global macro concerns which has dampened investor enthusiasm over the past two months.
In this article: BMY, FBIOX, IBB, QQQ, AMGN, GILD, XBI, XLV, ABBV, BLUE, FMI Also: RHHBY, BIIB
Read

PARTNER HEADLINES

Latest Tweets for $BMY

No tweets yet!